4-((3-((4-(CYCLOPROPYLCARBONYL)-2,3-DIHYDRO-1(4H)-PYRAZINYL)CARBONYL)-4-FLUOROPHENYL)METHYL)-1(2H)-PHTHALAZINONE
UNII 5UY5AF25B9
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-((3-((4-(cyclopropylcarbonyl)-2,3-dihydro-1(4h)-pyrazinyl)carbonyl)-4-fluorophenyl)methyl)-1(2h)-phthalazinone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5UY5AF25B9.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2248670-14-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H21FN4O3 ZXUONGKYSIPXCB-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-((3-((4-(cyclopropylcarbonyl)-2,3-dihydro-1(4h)-pyrazinyl)carbonyl)-4-fluorophenyl)methyl)-1(2h)-phthalazinone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.